Mattke, M. http://orcid.org/0000-0002-7683-3776
Rath, D.
Häfner, M. F.
Unterhinninghofen, R.
Sterzing, F.
Debus, J.
Giesel, F. L.
Funding for this research was provided by:
Klaus Tschira Stiftung
Universitätsklinikum Heidelberg
Article History
Received: 26 November 2020
Accepted: 27 April 2021
First Online: 22 May 2021
Declarations
:
: JD is the head of the department of Radiation Oncology in Heidelberg and the CEO of the Heidelberg Ion-Beam Therapy Center, he declares to receive grants from: Viewray Inc, CRI The Clinical Research Institute GmbH, Accuray International Sari, RaySearch Laboratories AB, Vision RT Limited, Merck Serono GmbH, Astellas Pharma GmbH, Astra Zeneca GmbH, Siemens Healthcare GmbH, Solution Akademie GmbH, Egomed PLC Surrey Research Park, Quintiles GmbH, Pharmaceutical Research Associates GmbH, Boehringer Ingelheim Pharma GmbH&CoKG, PTW-Freiburg Dr. Pychlau GmbH, Nanobiotix S.A, Accuray Incorporated.
: The study was approved by the ethics committee of the university of Heidelberg.